Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,474 | 79 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $372.50 | 21 | $0 (2024) |
| Amgen Inc. | $133.15 | 5 | $0 (2024) |
| PFIZER INC. | $122.07 | 7 | $0 (2023) |
| Dermavant Sciences, Inc. | $117.65 | 2 | $0 (2023) |
| Celgene Corporation | $90.99 | 4 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $90.23 | 5 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $90.16 | 5 | $0 (2017) |
| Mission Pharmacal Company | $77.39 | 5 | $0 (2018) |
| Almirall LLC | $62.38 | 4 | $0 (2022) |
| Mayne Pharma Inc. | $51.48 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $203.43 | 8 | E.R. Squibb & Sons, L.L.C. ($146.54) |
| 2023 | $296.26 | 19 | E.R. Squibb & Sons, L.L.C. ($225.96) |
| 2022 | $192.23 | 7 | Dermavant Sciences, Inc. ($98.74) |
| 2021 | $186.93 | 10 | Amgen Inc. ($76.26) |
| 2020 | $15.92 | 1 | Regeneron Healthcare Solutions, Inc. ($15.92) |
| 2019 | $150.56 | 8 | Celgene Corporation ($49.38) |
| 2018 | $196.02 | 12 | Mission Pharmacal Company ($59.79) |
| 2017 | $232.60 | 14 | Bayer HealthCare Pharmaceuticals Inc. ($90.16) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: Inflammation | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.13 | General |
| Category: Immunology | ||||||
| 06/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.75 | General |
| Category: Immunology | ||||||
| 06/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.85 | General |
| Category: Immunology | ||||||
| 04/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.56 | General |
| Category: Immunology | ||||||
| 01/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Inflammation | ||||||
| 01/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $121.87 | General |
| Category: Immunology | ||||||
| 01/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.38 | General |
| Category: Immunology | ||||||
| 10/27/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 10/24/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.17 | General |
| Category: Immunology | ||||||
| 09/19/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.77 | General |
| Category: Immunology | ||||||
| 08/03/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.40 | General |
| Category: Immunology | ||||||
| 07/31/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $133.33 | General |
| 07/26/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: DERMATOLOGY | ||||||
| 06/27/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.71 | General |
| Category: Immunology | ||||||
| 06/06/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.04 | General |
| Category: Immunology | ||||||
| 05/09/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.89 | General |
| Category: Immunology | ||||||
| 05/02/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.89 | General |
| Category: Immunology | ||||||
| 05/01/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: DERMATOLOGY | ||||||
| 04/24/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.36 | General |
| Category: Immunology | ||||||
| 04/12/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $18.71 | General |
| 04/11/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $5.15 | General |
| 04/06/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $4.26 | General |
| 03/21/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.10 | General |
| Category: Immunology | ||||||
| 03/14/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.18 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 664 | 914 | $309,491 | $133,745 |
| 2022 | 15 | 624 | 815 | $271,954 | $120,168 |
| 2021 | 19 | 705 | 956 | $334,614 | $154,130 |
| 2020 | 17 | 663 | 886 | $280,179 | $121,323 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 91 | 116 | $118,900 | $53,455 | 45.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 86 | 98 | $40,866 | $19,871 | 48.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 39 | 64 | $32,800 | $19,719 | 60.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 49 | 58 | $22,910 | $5,628 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 102 | $11,675 | $5,576 | 47.8% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 23 | 25 | $9,610 | $5,134 | 53.4% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 42 | 45 | $15,835 | $5,019 | 31.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 64 | 77 | $11,935 | $4,920 | 41.2% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 31 | 31 | $12,201 | $3,813 | 31.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 22 | 33 | $4,884 | $2,597 | 53.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 45 | 66 | $7,194 | $2,188 | 30.4% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 18 | 20 | $9,580 | $2,185 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 15 | $2,475 | $1,344 | 54.3% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 16 | $3,856 | $968.85 | 25.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 17 | 21 | $1,722 | $749.25 | 43.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 28 | 127 | $3,048 | $577.95 | 19.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 102 | 109 | $111,725 | $52,053 | 46.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 71 | 79 | $32,943 | $16,121 | 48.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 39 | 50 | $24,750 | $15,580 | 63.0% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2022 | 54 | 55 | $18,191 | $6,034 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 82 | $8,930 | $4,829 | 54.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2022 | 43 | 52 | $20,540 | $4,730 | 23.0% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2022 | 18 | 19 | $6,980 | $4,387 | 62.9% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2022 | 31 | 33 | $12,309 | $4,265 | 34.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 58 | 64 | $9,920 | $3,831 | 38.6% |
About Dr. Marlene Willen, MD
Dr. Marlene Willen, MD is a Dermatology healthcare provider based in Independence, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215955661.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marlene Willen, MD has received a total of $1,474 in payments from pharmaceutical and medical device companies, with $203.43 received in 2024. These payments were reported across 79 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,474).
As a Medicare-enrolled provider, Willen has provided services to 2,656 Medicare beneficiaries, totaling 3,571 services with total Medicare billing of $529,366. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Independence, OH
- Active Since 07/17/2006
- Last Updated 06/29/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1215955661
Products in Payments
- Sotyktu (Drug) $229.76
- Otezla (Drug) $224.14
- VTAMA (Drug) $117.65
- EUCRISA (Drug) $105.96
- DUPIXENT (Biological) $100.56
- Finacea (Drug) $90.16
- DORYX (Drug) $51.48
- Seysara (Drug) $49.04
- ENSTILAR (Drug) $46.61
- Winlevi (Drug) $28.89
- Erivedge (Biological) $28.74
- DUPIXENT DUPILUMAB INJECTION (Biological) $23.36
- Plexion (Drug) $17.60
- INNOVAMATRIX AC (Device) $16.44
- Bensal HP (Drug) $16.14
- CIBINQO (Drug) $16.11
- Avar (Drug) $15.00
- OPZELURA (Drug) $14.77
- COSENTYX (Biological) $14.10
- Cordran (Drug) $13.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Independence
Mary Sivik, Md, MD
Dermatology — Payments: $6,621
Dr. Farhaad Riyaz, Md, MD
Dermatology — Payments: $3,633
Connie Sutter, Md, MD
Dermatology — Payments: $3,437
Anand Rajpara, M.d, M.D
Dermatology — Payments: $3,092
Carol Burg, Md, MD
Dermatology — Payments: $2,476
Peter Muelleman
Dermatology — Payments: $436.97